MedPath

PRED MILD

PRED MILD (prednisolone acetate ophthalmic suspension, USP) 0.12%

Approved
Approval ID

4c1ec8d2-9128-402e-a723-87dc7b444655

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 2, 2013

Manufacturers
FDA

Physicians Total Care, Inc.

DUNS: 194123980

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

prednisolone acetate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-6355
Application NumberNDA017100
Product Classification
M
Marketing Category
C73594
G
Generic Name
prednisolone acetate
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateJanuary 2, 2013
FDA Product Classification

INGREDIENTS (10)

prednisolone acetateActive
Quantity: 1.2 mg in 1 mL
Code: 8B2807733D
Classification: ACTIB
boric acidInactive
Code: R57ZHV85D4
Classification: IACT
benzalkonium chlorideInactive
Code: F5UM2KM3W7
Classification: IACT
hypromellosesInactive
Code: 3NXW29V3WO
Classification: IACT
edetate disodiumInactive
Code: 7FLD91C86K
Classification: IACT
polysorbate 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
waterInactive
Code: 059QF0KO0R
Classification: IACT
sodium chlorideInactive
Code: 451W47IQ8X
Classification: IACT
sodium bisulfiteInactive
Code: TZX5469Z6I
Classification: IACT
sodium citrateInactive
Code: 1Q73Q2JULR
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PRED MILD - FDA Drug Approval Details